Last updated: 2026-10-15 08:26:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Bluejay Diagnostics, Inc. (BJDX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $0.77, with a market capitalisation of $861.19K and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.76 to $14.00. This page covers its latest market performance, valuation, price trends and company information.
$861.19K | |
$0.78 | |
$200,000.00 | |
$0.76 | |
$0.79 | |
2.78K | |
3.27M | |
-- | |
$14.00 | |
$0.76 | |
-- | |
-- |
Bluejay Diagnostics, Inc. (BJDX) is trading at $0.77 in pre-market trading as of 2026-10-15 08:07:00, down 2.59% ($0.02) from the previous close of $0.79
Pre-market trading shows how investors are pricing BJDX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Bluejay Diagnostics, Inc. (BJDX) moved from $0.81 to $0.77, representing a decline of 5.39% ($0.04).
The stock traded between $0.76 and $0.84 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.13 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.1%
BJDX is currently trading at $0.77, placing it 0.1% of the way from its 52-week low of $0.76 to its 52-week high of $14.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Bluejay Diagnostics, Inc. (BJDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.